Evidence map›Paper›PMID 33154471›Full record

Observational studyScientific reports2020

Dual antiplatelet therapy reduced stroke risk in transient ischemic attack with positive diffusion weighted imaging.

Lu-Lu Pei, Pei Chen, Hui Fang, Yuan Cao, Yi-Nan Guo, Rui Zhang, Lu Zhao, Yuan Gao, Jun Wu, Shi-Lei Sun and 6 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Lu-Lu PeiDepartment of Neurology, Henan Key Laboratory of Cerebrovascular Disease, the First Affiliated Hospital of Zhengzhou University At Zhengzhou, 1st Jianshe Eastern Road, Zhengzhou, 450052, Henan, China.
Pei ChenDepartment of Neurology, Henan Key Laboratory of Cerebrovascular Disease, the First Affiliated Hospital of Zhengzhou University At Zhengzhou, 1st Jianshe Eastern Road, Zhengzhou, 450052, Henan, China.
Hui FangDepartment of Neurology, Henan Key Laboratory of Cerebrovascular Disease, the First Affiliated Hospital of Zhengzhou University At Zhengzhou, 1st Jianshe Eastern Road, Zhengzhou, 450052, Henan, China.
Yuan CaoDepartment of Neurology, Henan Key Laboratory of Cerebrovascular Disease, the First Affiliated Hospital of Zhengzhou University At Zhengzhou, 1st Jianshe Eastern Road, Zhengzhou, 450052, Henan, China.
Yi-Nan GuoDepartment of Neurology, Henan Key Laboratory of Cerebrovascular Disease, the First Affiliated Hospital of Zhengzhou University At Zhengzhou, 1st Jianshe Eastern Road, Zhengzhou, 450052, Henan, China.
Rui ZhangDepartment of Neurology, Henan Key Laboratory of Cerebrovascular Disease, the First Affiliated Hospital of Zhengzhou University At Zhengzhou, 1st Jianshe Eastern Road, Zhengzhou, 450052, Henan, China.
Lu ZhaoDepartment of Neurology, Henan Key Laboratory of Cerebrovascular Disease, the First Affiliated Hospital of Zhengzhou University At Zhengzhou, 1st Jianshe Eastern Road, Zhengzhou, 450052, Henan, China.
Yuan GaoDepartment of Neurology, Henan Key Laboratory of Cerebrovascular Disease, the First Affiliated Hospital of Zhengzhou University At Zhengzhou, 1st Jianshe Eastern Road, Zhengzhou, 450052, Henan, China.
Jun WuDepartment of Neurology, Henan Key Laboratory of Cerebrovascular Disease, the First Affiliated Hospital of Zhengzhou University At Zhengzhou, 1st Jianshe Eastern Road, Zhengzhou, 450052, Henan, China.
Shi-Lei SunDepartment of Neurology, Henan Key Laboratory of Cerebrovascular Disease, the First Affiliated Hospital of Zhengzhou University At Zhengzhou, 1st Jianshe Eastern Road, Zhengzhou, 450052, Henan, China.
Xiao-Ying WangDepartments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Eng H LoDepartments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Ferdinando S BuonannoDepartment of Neurology, Clinical Proteomics Research Center and Cardio-Neurology Clinic, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Ming-Ming NingDepartment of Neurology, Clinical Proteomics Research Center and Cardio-Neurology Clinic, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Yu-Ming XuDepartment of Neurology, Henan Key Laboratory of Cerebrovascular Disease, the First Affiliated Hospital of Zhengzhou University At Zhengzhou, 1st Jianshe Eastern Road, Zhengzhou, 450052, Henan, China. xuyuming@zzu.edu.cn.
Bo SongDepartment of Neurology, Henan Key Laboratory of Cerebrovascular Disease, the First Affiliated Hospital of Zhengzhou University At Zhengzhou, 1st Jianshe Eastern Road, Zhengzhou, 450052, Henan, China. songbo76@sina.com.
First Affiliated Hospital of Zhengzhou University · CNHarvard University · USMassachusetts General Hospital · US

Funding

Proteomic Profiling of Patent Foramen Ovale Related Neurovascular InjuryR01NS067139 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI NING, MINGMING · 2010 to 2023
$3.7M
Thrombolysis Profiles in tPA ResponseR01NS093415 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI LO, ENG H., NING, MINGMING · 2015 to 2019
$1.9M
Glycoproteomics in Ischemic Stroke Related HyperglycemiaR21NS113065 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI NING, MINGMING · 2020 to 2020
$462k
NINDS NIH HHS R01 NS067139NINDS NIH HHS R01 NS093415NINDS NIH HHS R21 NS113065
6 · The paper itself

Abstract

Dual antiplatelet therapy (DAPT) reduced stroke risk in high-risk transient ischemic attack (TIA) patients assessed by ABCD2 score. Patients with positive diffusion-weighted imaging (DWI) were identified as imaging-based high-risk. The present study aims to investigate whether DAPT could reduce stroke risk in TIA with DWI positive. The study enrolled TIA patients within 72 h of onset from the prospective TIA database of the First Affiliated Hospital of Zhengzhou University. The predictive outcome was ischemic stroke at 90-day. The relationship between DAPT and stroke was analyzed in a cox proportional hazards model. The Kaplan-Meier curves of TIA patients with DAPT and monotherapy were plotted. Total of 661 TIA patients were enrolled, 279 of whom were DWI positive and 281 used DAPT. The 90-day stroke risk was higher in patients used monotherapy than those used DAPT in TIA with positive DWI (23.7% vs. 13.4%, p = 0.029). DAPT was associated with reduced stroke risk in TIA patients with positive DWI (hazard ratio [HR] = 0.54; 95% confidence interval [CI], 0.30-0.97; p = 0.037). However, the benefit didn't exist in TIA patients with negative DWI (HR = 0.43; 95% CI, 0.14-1.33; p = 0.142). Early use of DAPT reduced stroke risk in TIA patients with positive DWI.

Indexed as

AdultAgedAspirinBrainClopidogrelDiffusion Magnetic Resonance ImagingDrug Therapy, CombinationFemaleHumansIschemic Attack, TransientIschemic StrokeMaleMiddle AgedPlatelet Aggregation InhibitorsPrognosisTreatment OutcomeAspirinClopidogrelPlatelet Aggregation Inhibitors

Identifiers

PMID33154471
PMCPMC7644691
OpenAlexW3095348553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.